Inhibition of in vitro adherence of antibody-coated red cells to monocytes by the dialyzable leukocyte extract.
The red cell-monocyte assay (RMA), which has been used to evaluate the clinical significance of red cell (RBC) antibodies, was employed to test the effect of the dialyzable leukocyte extract (DLE) on in vitro adherence to monocytes of human RBCs coated with alloantibodies or autoantibodies. The total association index (TAI) of the RMA, expressing the number of RBCs adhering to or phagocytosed by 100 monocytes, indicated a potent inhibitory activity of DLE in the test system. TAI values of 100.4 +/- 20.1 (mean +/- SD) in the control sample, consisting of RBCs coated in vitro with anti-D, dropped to 4.0 +/- 2.1 when DLE was present in the assay medium at a concentration of 0.5 U per mL. Similar results were obtained with RBCs coated with IgG antibodies in vivo. The inhibition was dose dependent and was associated with a thermolabile component of DLE. This study establishes that DLE can modulate monocyte function by inhibiting the recognition of IgG sensitized red cells.
Rebulla
P
P
Centro Trasfusionale e di Immunologia dei Trapianti, Ospedale Policlinico, Milan, Italy.
Tedesco
F
F
Radillo
O
O
Battaglioli
M
M
Boeri
M
M
Rosso di San Secondo
V E
VE
Sirchia
G
G
D002448:Cell Adhesion / Q000187:drug effects; D004912:Erythrocytes / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D008722:Methods; D009000:Monocytes / Q000166:cytology*; D010587:Phagocytosis / Q000187:drug effects; D014165:Transfer Factor / Q000494:pharmacology*
D007074:Immunoglobulin G; D014165:Transfer Factor